This registry aims to monitor the safety of Xueshuantong Injection and to identify the potential risk factors for the adverse drug reactions.
Xueshuantong-Injection is a kind of natural compound injection with Panax notoginseng saponins(PNS). It's a popular drug for improving blood circulation that focusing on central retinal vein occlusion, stroke sequela, internal ophthalmopathy, hyphema and so on. However, more and more case reports about the adverse drug events of Panax notoginseng saponins have been reported in recent years. Therefore, this registry of Xueshuantong-Injection aims to monitor the safety and find the incidence of adverse drug reactions to Xueshuantong-Injection. Moreover, this registry is highly concerned on identifying the potential risk factors for the adverse drug reactions.
Study Type
OBSERVATIONAL
Enrollment
30,000
Xueshuantong-Injection is a kind of natural compound injection extracted from Chinese herb Notoginseng. The major bioactive ingredient is panax notoginseng saponins.
Jizhou City Hospital
Hengshui, Hebei, China
RECRUITINGTongbai County People's Hospital
Nanyang, Henan, China
The incidence of severe adverse reactions (SAR) of Xueshuantong-Injection
A serious adverse reactions (SAR) is any untoward medical occurrence suspected to be medicinal product-related that at any dose: Results in death, is life-threatening, NOTE: The term "life-threatening" in the definition of "serious" refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe. Requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, or Is a congenital anomaly/birth defect.
Time frame: 2 years
The incidence of adverse drug reactions (ADR) of Xueshuantong-Injection
Time frame: 2 years
The incidence of adverse events (AE)of Xueshuantong-Injection
Time frame: 2 years
The incidence of serious adverse events (SAE)of Xueshuantong-Injection
Time frame: 2 years
The incidence of anaphylactic reaction of Xueshuantong-Injection
Time frame: 2 years
The incidence of new ADRs of Xueshuantong-Injection
Time frame: 2 years
The effective rate of Xueshuantong-Injection
The proportion of the patients whose drug effect is considered as "effective" by investigator
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Lingbao 3th People's Hospital
Sanmenxia, Henan, China
RECRUITINGPeople's Hospital of Dancheng County
Zhoukou, Henan, China
RECRUITINGDongxihu District People's Hospital
Wuhan, Hubei, China
RECRUITINGDonghai Country People's Hospital
Lianyungang, Jiangsu, China
RECRUITINGPeople's Hospital of Yichun City
Yichun, Jiangxi, China
RECRUITINGCentral Hospital of Wafangdian City
Dalian, Liaoning, China
RECRUITINGLingyuan City Central Hospital
Lingyuan, Liaoning, China
RECRUITINGChinse Medical Hospital of Yangxin County
Binzhou, Shandong, China
RECRUITING...and 4 more locations